I[NTRODUCTION]{.smallcaps} {#sec1-1}
==========================

Electrolytes are charged elements that are important for various functioning of the body. They play an important role in physiological, biochemical, and metabolic functions such as cell membrane potential generation, neurohormonal pathways coordination, energy generation, and acid--base balance in the body.\[[@ref1]\]

Almost all metabolic processes are directly coordinated by the electrolytes. Minor-to-major variation in electrolyte values either can be due to a variety of disorders or can also be the cause of multiple complications. They can be acute or chronic and can result in life-threatening problems.\[[@ref2]\] Whatever may be the reason ensuring adequate treatment is always required to reverse the metabolic disturbances.

Electrolyte values are measured both by arterial--blood gas (ABG) analyzers and central laboratory autoanalyzers (AA). In Intensive Care Unit (ICU) setups, intensivist mainly uses the point-of-care measurement of electrolytes by ABG analyzer to combat the time gap and prompt treatment. Typically, a turnaround time of about 2 h for obtaining the laboratory report is noted on average in acute care laboratories of most tertiary care hospitals in the developing countries.\[[@ref3]\]

The delay in obtaining the laboratory reports is often because of the delay in transporting samples to the central laboratory, either due to lack of sufficient numbers of human couriers or the absence of rapid transit systems (RTSs).\[[@ref3]\]

The technology for detecting the electrolyte assay both of the ABG and the AA is ion-sensing electrode method. It is used in most of the hospitals.\[[@ref4]\] The indirect assay is preanalytical dilution of the sample, sending them to laboratory, and sensing the electrode by flame photometry (the recognized reference method), subsequently finding out the result.\[[@ref4]\]

In the point-of-care technology, the electrode surface comes in contact with a complete undiluted blood sample and senses the movement of the electrolytes by the ISE technology. Sodium and potassium levels measured in the whole blood and plasma have been shown to be essentially identical.\[[@ref5]\] Hence, we assume that the blood and the plasma used for electrolyte measurement in ABG and AA, respectively, should be equal.\[[@ref6]\]

A lot of studies are published about the comparison of these two methods, and it has been already proved beyond doubt that there remains a highly significant difference statistically in between the electrolytes measured by these two methods.\[[@ref7][@ref8]\]

In this study, we tried to find out the correction factor for sodium and potassium and then correlating the corrected ABG electrolyte values with the laboratory values.

M[ATERIALS AND]{.smallcaps} M[ETHODS]{.smallcaps} {#sec1-2}
=================================================

We have prospectively studied 100 samples of patients hospitalized in ICU from September 2016 to December 2016. The study was approved by the Ethics Committee of the hospital. Arterial blood samples were collected in heparinized blood--gas syringes; 1.5 ml of blood collected in the commercially available plastic 2.0 ml syringe (Dispovan single-use syringe) preflushed with 1 ml of heparin and analyzed using ABL 800 basic blood--gas analyzer immediately which employs direct ISE technology. We take a further sample at the same time, from the same arterial line samples and sent, pneumatically sealed in BD vacutainer serum tube and analyzed within 2 h, to our central laboratory, where serum Na+ and K+ concentrations were analyzed via indirect ISE on a Beckman Coulter AU640 MODEL.

Inclusion criteria {#sec2-1}
------------------

Age between 18 and 70 yearsPatients whose paired blood samples could simultaneously be collected from an arterial catheter.

Exclusion criteria {#sec2-2}
------------------

Negative informed consentAge under 18 or \>70 yearsNo arterial catheterBlood samples could not simultaneously be collected.

These samples were collected only when clinically indicated. All samples collected by the specially trained nursing staff.

Analytical precision of sodium and potassium determination {#sec2-3}
----------------------------------------------------------

The blood--gas analyzer is calibrated every 4 hourly with the aid of an in machine calibrator provided by the supplier, in line with daily internal quality control (QC) standards according to the manufacturer\'s recommendation. An external QC check is performed weekly.

In the laboratory for correct data analysis, we run a two-level QC test every 12 hourly using daily internal QC standards. The central laboratory is accredited to NABL, External Quality Assurance Scheme (EQAS) for quality and standard maintenance.

Statistical methods employed {#sec2-4}
----------------------------

Data were evaluated using "MedCalc." Means, standard deviations (SDs), and coefficients of variation were calculated. Karl Pearson\'s correlation coefficients were found out. Deming regression analysis was performed, and Bland--Altman plots were constructed to compare the results of the two methods. *P* \< 0.0001 was considered statistically significant.

R[ESULTS]{.smallcaps} {#sec1-3}
=====================

The calculation of an adequate sample size becomes crucial in any clinical study. It is the optimum number of participants required to arrive at ethically and scientifically valid results. Generally, the sample size for any study depends on the following acceptable level of significance, power of the study, expected effect of size, underlying event rate in the population, and SD in the population.

We did a pilot study initially to find out the sample size. Taking α at 0.05 and desired power of study is 80%, the sample size needed is 100.

There is statistically no significant difference among the patients according to their gender distribution and age \[Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}\]The mean sodium concentration was 130.27 mmol/L ± SD 7.85 mmol/L using ABG and 139.28 mmol/L ± SD 7.89 mmol/L using the AA \[[Table 3](#T3){ref-type="table"}\]The mean potassium concentration was 3.542 mmol/L ± SD 0.76 mmol/L using ABG and 4.196 mmol/L ± SD 0.72 mmol/L using the AA \[[Table 4](#T4){ref-type="table"}\]The extent of inter-analyzer agreement was unacceptable for both Na+ and K+ \[Figures [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}\]The associated "Karl Pearson\'s correlation coefficients" of Na+ was *R*^2^ = 0.9194, *r* = 0.9589 and of K+ was *R*^2^ = 0.8615, *r* = 0.9282, respectively \[Figures [3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}\]Deming regression analysis of the ABG and AA data on Na+ levels yielded the following formula: *y* = 0.9633x + 13.797 \[[Figure 4](#F4){ref-type="fig"}\]Deming regression analysis of the ABG and AA data on K+ levels yielded the following formula: *y* = 0.8731x + 1.1035 \[[Figure 3](#F3){ref-type="fig"}\]We conclude that the ABG and AA do not yield equivalent Na+ and K+ data. Concordance between ABG and AA should be established the following correction.For sodium (Na+): The maximum difference is 13 mmol/L and minimum difference is 1 mmol/L. Mean: 9.01 mmol/L ± 2.25 mmol/L \[[Figure 1](#F1){ref-type="fig"}\]Correction factor: current difference = 9.01, standard error = 1.113, 95% class interval = 6.815--11.205 considering correction factor with 2%--5% calibration.For potassium (K+): The maximum difference is 1.7 mmol/L and minimum difference is 0.1 mmol/L. Mean: 0.654 mmol/L ± 0.28 mmol/L \[[Figure 2](#F2){ref-type="fig"}\].Correction factor: current difference = 0.654, standard error = 0.1047, 95% class interval = 0.4475--0.8605 considering correction factor with 2%--5% calibration.The correction factor is then checked for validity.Mean ± SD of potassium in ABG was 3.33 ± 0.50 and AA was 4.18 ± 0.62 for the next group \[[Table 5](#T5){ref-type="table"}\]. The paired *t*-test depicts statistically significant difference. No statistical difference exists when AA is compared with ABG and correction factor (mean ± SD: 4.00 ± 0.52) taken into account and compared with each other \[[Table 5](#T5){ref-type="table"}\]Mean ± SD of sodium in ABG was 129.87 ± 6.90 and AA was 138.18 ± 7.73 for the next group \[[Table 5](#T5){ref-type="table"}\]. The paired *t*-test depicts statistically significant difference. No statistical difference exists when AA is compared with ABG and correction factor (mean ± SD: 138.88 ± 6.91) taken into account and compared with each other \[[Table 6](#T6){ref-type="table"}\].
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Sex distribution among the patients
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Age distribution among the patients
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The mean and standard deviation of sodium level measured by arterial blood gas and laboratory result
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###### 

The mean and standard deviation of potassium level measured by arterial blood gas and laboratory result
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![The Bland--Altman difference plot for sodium derived from the arterial blood gas and AA values](IJCCM-22-34-g005){#F1}

![Bland--Altman difference plot for potassium for arterial blood gas and AA values](IJCCM-22-34-g006){#F2}

![The equation derived from Karl Pearson\'s correlation coefficient with linear regression analysis was used to potassium level (in arterial blood gas) by potassium level (in laboratory). The line of regression was, *y* = 0.8731x + 1.1035 with *R*^2^ = 0.8615 and *r* = 0.9282 (strongly correlated)](IJCCM-22-34-g007){#F3}

![The equation derived from Karl Pearson\'s correlation coefficient with linear regression analysis was used to sodium level (in arterial blood gas) by Sodium level (in laboratory). The line of regression was, *y* = 0.9633x + 13.797 with *R*^2^ = 0.9194 and *r* = 0.9589 (strongly correlated)](IJCCM-22-34-g008){#F4}

###### 

The calculated mean and standard deviation of potassium level measured by arterial blood gas and laboratory result after validating correction factor
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###### 

The calculated mean and standard deviation of sodium level measured by arterial blood gas and laboratory result after validating correction factor
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D[ISCUSSION]{.smallcaps} {#sec1-4}
========================

The patients in ICU require more frequent monitoring of the metabolic parameter. Hence, RTS for decreasing the lag time and dedicated laboratory services for emergency and ICU is always required. However, a greater number of hospitals still do not have such high-end facilities. Point-of-care approach of monitoring is done to have rapid bedside result that can help in quick decision and making prompt treatment.\[[@ref9]\] The labor costs, reagent cost, and analysis cost are also reduced when compared with the central laboratory analyzing costs.\[[@ref10]\]

It is known that patients in ICUs are critically ill and tend to have low blood protein levels. The ABG results are not affected by serum protein levels, which make the ABG electrolyte results more accurate for critically ill patients.\[[@ref11]\] Moreover, patients can have pseudohyponatremia if protein or cholesterol level is on the rise in ICU patients. Considering using ABG only for evaluating electrolytes can have an high operational cost, but when we consider in total, the amount of information, we get from an ABG, in a critically ill patient such as the oxygen requirement, lactate level, and acidosis *per se*, the use of ABG machines at critical areas of hospitals such as emergency department, operation theaters, and ICUs are well justified. Furthermore, the direct cost of the machine to the hospital has been on decreasing trend as the supply of such analyzers increases with time.\[[@ref12]\]

In the study conducted by Morimatsu *et al*., it was revealed that results with AA and ABG differed significantly for the plasma sodium and chloride levels. The mean plasma sodium concentration was 140.4 ± 5.6 mmol/L with central laboratory testing versus 138.3 ± 5.9 mmol/l with point-of-care testing (*P* \< 0.0001). The mean plasma chloride concentration was 102.4 ± 6.5 mmol/L versus 103.4 ± 6.0 mmol/L (*P* \< 0.0001).\[[@ref13]\]

Furthermore, Chacko *et al*. also concluded that the differences in the measured sodium levels between the two methods were significant. There was a significant difference in the mean ± SD of sodium value between whole blood and serum samples, 135.8 ± 5.7 mmol/L versus 139.9 ± 5.4 mmol/L (*P* \< 0.001). Although the agreement between whole blood and serum potassium was good, and the average difference was small, still the individual differences were clinically significant, particularly at lower potassium values.\[[@ref7]\]

Consistent with the literature, our study also found a significant difference between the two methods for analysis of sodium and potassium levels. Thus, making clinical decisions for sodium and potassium according to ABG seems unreliable. The mean sodium concentration was 130.27 mmol/L ± SD 7.85 mmol/L using ABG and 139.28 mmol/L ± SD 7.89 mmol/L using the AA \[[Table 3](#T3){ref-type="table"}\]. The mean potassium concentration was 3.542 mmol/L ± SD 0.76 mmol/L using ABG and 4.196 mmol/L ± SD 0.72 mmol/L using the AA \[[Table 4](#T4){ref-type="table"}\]. These differences do significantly affect the calculation of the anion gap values and can lead physicians to different assessments of the acid--base and electrolyte levels.

Foremost, each instrument uses a different sample; autoanalyzer (AA) uses serum and ABG uses whole blood. Actually electrolyte analysis should be performed on serum, which is the portion of blood without cells or clotting factors. Serum has no contribution that hemolyzed cells might make to the sample. Among electrolytes, potassium, in particular, is stored primarily within the cell; this presents a problem in analyzing whole-blood samples that can undergo hemolysis, which releases potassium from the cell and can cause a falsely elevated value. Factors that can cause hemolysis in a sample include small needle size, rough handling, incorrect temperature, and elapsed time. It mainly occurs due to prolonged storage at low temperatures or prolonged time between sampling and analysis.\[[@ref14][@ref15]\] Although Flegar-Mestrić and Perkov debated on the fact that K levels measured in whole blood and plasma have been shown to be essentially same\[[@ref16]\] and the release of K from platelets during clotting may cause statistically insignificant increase of levels in serum.\[[@ref6]\]

The above reason can lead to overestimation of potassium or other intercellular electrolytes in the ABG sample as whole blood is used for the test which was not evident in our study.

However, some studies projected the fact that overestimation or erroneous result is actually from the laboratory and is of the indirect ISE values. They brought the fact that the measurement is clearly linked to serum protein and albumin levels. Story *et al*. have reported that indirect ISE leads to overestimation of Na in hypoalbuminemia. The difference between direct and indirect ISE results was found to correlate with serum albumin and total protein concentrations.\[[@ref17][@ref18]\]

Other reasons can be dilution with flush fluid when sampling from a catheter. Or different heparin volumes in ABG sampling syringes dilute the whole blood and lower the levels of measured electrolytes in ABG testing.\[[@ref19]\] The heparin being negatively charged also binds with the electrolytes, thereby lowering its value by decreasing their movement which is actually the technology of their detection.\[[@ref20][@ref21]\] Thus, we strongly agree with Chow *et al*., who reported that direct ISE sodium and potassium figures were lower than those obtained using indirect ISE.\[[@ref18]\]

The wide variability, as shown in the Bland--Altman plots, and the statistically significant mean differences in measured electrolyte levels between the two analyzers suggest that the tests do not yield equivalent data. As our laboratory is accredited to EQAS for quality and standard maintenance, we keep on checking the sample with multiple external laboratory data. Hence, we consider it as reference value for all our measurements and treatments.

Taking things one step forward to compensate the variation, we tried to find a correction factor and then add it up with the ABG value for appropriation of the ABG value with the AA. The question is whether such compensation is appropriate. Rouse in his study first talked about this concept and usage of a correction factor may minimize the differences between the analyzing instruments.\[[@ref22]\]

We found out that the concordance between ABG and AA can be established for sodium by correction factor of 9.01 mmol/L \[[Figure 1](#F1){ref-type="fig"}\] and for potassium (K+) correction factor of 0.654 mmol/L \[[Figure 2](#F2){ref-type="fig"}\]. We validated the appropriate use of it by taking 30 patients' ABG electrolyte values from January 2017 to March 2017 and adding the correction factor to it and then correlating it to their respective AA values. The results showed were statistically nonsignificant.

The limitations of our study are use of one AA and one ABG machine and the ABG samples were collected using conventional syringes containing liquid heparin. The use of dried heparin syringes could improve the accuracy of the results by decreasing the dilution of the sample.

C[ONCLUSION]{.smallcaps} {#sec1-5}
========================

The correction factor should be determined individually for each hospital. It is important for each center to perform its own studies with regard to concordance. As instrument type and calibration methods may differ among hospitals, it is important that each center conduct an in-hospital study ideally before installation of an ABG, and both the instruments should be calibrated accordingly.
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